<DOC>
	<DOCNO>NCT00829127</DOCNO>
	<brief_summary>The aim study evaluate safety , tolerability pharmacokinetics AZD8075 healthy male subject increase dos give 14 day</brief_summary>
	<brief_title>AZD8075 Study Assess Safety , Tolerability Pharmacokinetics Multiple Ascending Oral Doses AZD8075 Healthy Male Volunteers</brief_title>
	<detailed_description />
	<criteria>Provision sign , write date informed consent prior study specific procedure Have body mass index ( BMI ) 19 30 kg/m2 weigh least 50 kg 100 kg Be nonsmoker exsmoker stop smoke ( use nicotine product ) &gt; 6 month prior study start Any clinically significant disease disorder , opinion investigator , may either put subject risk participation study , influence result study , subject 's ability participate Any clinically relevant abnormal finding phys.examination , clinical chemistry , haematology , urinalysis , vital sign ECG baseline , , opinion investigator , may put subject risk participation study Participation another investigational drug study within 3 month Visit 2 participation method development study ( drug ) 1 month prior Visit 2</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>volunteer</keyword>
</DOC>